The analysis of risk factors for diabetic kidney disease progression: a single-centre and cross-sectional experiment in Shanghai.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
28 06 2022
Historique:
entrez: 29 6 2022
pubmed: 30 6 2022
medline: 2 7 2022
Statut: epublish

Résumé

To identify the risk factors for diabetic kidney disease (DKD) development, especially the difference between patients with different courses. 791 patients were considered to be eligible and were enrolled in the cross-sectional study from Shanghai Tongren Hospital Inpatient Department. 36 variables were initially screened by univariate analysis. The risk factors affecting progression of DKD were determined by logistics regression analysis. Subgroups were grouped according to the course of diabetes disease, and multivariate logistics regression analysis was performed to find out the different risk factors in two subgroups. Finally, the receiver operating characteristics curve is used to verify the result. The logistic regression model indicated age (OR=1.020, p=0.017, 95% CI 1.004 to 1.040), systolic blood pressure (OR=1.013, p=0.006, 95% CI 1.004 to 1.022), waist circumference (OR=1.021, p=0.015, 95% CI 1.004 to 1.038), white blood cells (WBC, OR=1.185, p=0.001, 95% CI 1.085 to 1.295) and triglycerides (TG, OR=1.110, p=0.047, 95% CI 1.001 to 1.230) were risk factors for DKD, while free triiodothyronine (fT3, OR=0.711, p=0.011, 95% CI 0.547 to 0.926) was a protective factor for DKD in patients with type 2 diabetes mellitus (T2DM). Subgroup analysis revealed that in patients with a short duration of diabetes (<8 years), WBC (OR=1.306, p<0.001, 95% CI 1.157 to 1.475) and TG (OR=1.188, p=0.033, 95% CI 1.014 to 1.393) were risk factors for DKD,fT3 (OR=0.544, p=0.002, 95% CI 0.367 to 0.804) was a protective factor for DKD; whereas for patients with disease course more than 8 years, age (OR=1.026, Pp=0.012, 95%CI=95% CI[ 1.006- to 1.048]) was identified as the only risk factor for DKD and fT3 (OR=0.036, Pp=0.017, 95%CI=95% CI[ 0.439- to 0.922]) was a protective factor for DKD. The focus of attention should especially be on patients with a prolonged course of T2DM, and those with comorbid hypertension and hypertriglyceridaemia waist phenotype. More potential clinical indexes such as thyroid function and inflammatory indicators might be considered as early warning factors for DKD in T2DM. Women should pay attention to controlling inflammation and TGs, and men should strictly control blood pressure. Avoiding abdominal obesity in both men and women will bring great benefits.

Identifiants

pubmed: 35768116
pii: bmjopen-2021-060238
doi: 10.1136/bmjopen-2021-060238
pmc: PMC9240884
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e060238

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Nat Rev Nephrol. 2010 Jun;6(6):361-70
pubmed: 20440276
Diabetes Care. 2020 Mar;43(3):683-690
pubmed: 31932459
J Diabetes Investig. 2019 Nov;10(6):1543-1549
pubmed: 30884176
Prim Care Diabetes. 2021 Dec;15(6):1071-1074
pubmed: 34497035
Nephrol Dial Transplant. 2018 Jun 1;33(6):1001-1009
pubmed: 28992267
Medicina (Kaunas). 2021 Aug 25;57(9):
pubmed: 34577791
JAMA. 2016 Aug 9;316(6):602-10
pubmed: 27532915
Diabetes Care. 2020 Apr;43(4):925-933
pubmed: 32198286
Adv Chronic Kidney Dis. 2018 Mar;25(2):121-132
pubmed: 29580576
Diabetes Res Clin Pract. 2011 May;92(2):198-204
pubmed: 21320734
J Lipid Res. 2014 Mar;55(3):561-72
pubmed: 24371263
Int J Gen Med. 2020 Jul 06;13:351-360
pubmed: 32753935
Acta Diabetol. 2019 Aug;56(8):939-946
pubmed: 30927104
Ren Fail. 2021 Dec;43(1):1250-1258
pubmed: 34461808
Nat Rev Endocrinol. 2018 Feb;14(2):88-98
pubmed: 29219149
Eur Thyroid J. 2022 Feb 28;11(2):
pubmed: 35085102
Ann Clin Lab Sci. 2015 Spring;45(3):256-63
pubmed: 26116588
Ann Transl Med. 2018 Aug;6(15):305
pubmed: 30211193
Cardiovasc Diabetol. 2020 Jul 31;19(1):118
pubmed: 32736628
Diabetes Care. 2015 Oct;38(10):e174
pubmed: 26404939
Antioxidants (Basel). 2021 Nov 29;10(12):
pubmed: 34943023
BMJ. 2020 Apr 28;369:m997
pubmed: 32345662
Diabetes Care. 2005 Jul;28(7):1710-7
pubmed: 15983324
Clin Kidney J. 2018 Jun;11(3):342-347
pubmed: 29942497
J Diabetes Investig. 2017 Jan;8(1):6-18
pubmed: 27181363
Int J Mol Sci. 2021 May 01;22(9):
pubmed: 34062938
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045
pubmed: 28522654
Am J Nephrol. 2011;33(1):25-32
pubmed: 21150192
Cardiorenal Med. 2017 Oct;7(4):295-300
pubmed: 29118768
Sci Rep. 2018 Mar 16;8(1):4728
pubmed: 29549262
Int J Mol Sci. 2021 May 28;22(11):
pubmed: 34071671
Front Endocrinol (Lausanne). 2021 Dec 13;12:737586
pubmed: 34966356
J Diabetes Investig. 2021 Apr;12(4):557-565
pubmed: 33319507
J Diabetes Investig. 2019 May;10(3):745-752
pubmed: 30300472
Nutrients. 2018 Nov 05;10(11):
pubmed: 30400648
Int J Endocrinol. 2015;2015:204893
pubmed: 26697065
Ann Glob Health. 2020 Apr 24;86(1):43
pubmed: 32346524
JCI Insight. 2019 Sep 19;4(18):
pubmed: 31534055

Auteurs

Wen Liu (W)

Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China.

Juan Du (J)

Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China.

Xiaoxu Ge (X)

Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China.

Xiaohong Jiang (X)

Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China.

Wenfang Peng (W)

Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China.

Nan Zhao (N)

Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China.

Lisha Shen (L)

Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China.

Lili Xia (L)

Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China.

Fan Hu (F)

Shanghai Jiao Tong University School of Medicine, Shanghai, China joyking2003@163.com hs1147@126.com.

Shan Huang (S)

Tongren Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China joyking2003@163.com hs1147@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH